These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1406175)

  • 1. The effects of smokeless tobacco on performance and psychophysiological response.
    Landers DM; Crews DJ; Boutcher SH; Skinner JS; Gustafsen S
    Med Sci Sports Exerc; 1992 Aug; 24(8):895-903. PubMed ID: 1406175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of treatment on cardiovascular risk among smokeless tobacco users.
    Allen SS; Hatsukami D; Jensen J; Grillo M; Bliss R
    Prev Med; 1995 Jul; 24(4):357-62. PubMed ID: 7479625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of smokeless tobacco on the ability of secretory component to bind to the IgA/J chain complex.
    Gregory RL; Kindle JC; Hobbs LC; VanTo T; Malmstrom HS
    Hum Antibodies Hybridomas; 1990; 1(3):126-31. PubMed ID: 1966476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum total sialic acid levels in smokers and users of smokeless tobacco in form of oral powder (Maraş powder).
    Kurtul N; Cil MY; Paçaci SD
    J Biomed Sci; 2005; 12(3):559-63. PubMed ID: 15959629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of smokeless tobacco on the development of the CD-1 mouse fetus.
    Paulson R; Shanfeld J; Sachs L; Price T; Paulson J
    Teratology; 1989 Nov; 40(5):483-94. PubMed ID: 2623638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol and smokeless tobacco effects on the CD-1 mouse fetus.
    Paulson RB; Shanfeld J; Dean J; Mullet D; Fernandez M; Paulson JO
    J Craniofac Genet Dev Biol; 1992; 12(2):107-17. PubMed ID: 1613073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.
    Weinstein A; Brickner O; Lerman H; Greemland M; Bloch M; Lester H; Chisin R; Sarne Y; Mechoulam R; Bar-Hamburger R; Freedman N; Even-Sapir E
    J Psychopharmacol; 2008 Jun; 22(4):441-51. PubMed ID: 18635724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users.
    Ebbert JO; Dale LC; Patten CA; Croghan IT; Schroeder DR; Moyer TP; Hurt RD
    Nicotine Tob Res; 2007 Jan; 9(1):43-52. PubMed ID: 17365735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smokeless tobacco addiction: a threat to the oral and systemic health of the child and adolescent.
    Christen AG; McDonald JL; Olson BL; Christen JA
    Pediatrician; 1989; 16(3-4):170-7. PubMed ID: 2692003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual Tobacco use among Native American adults in southeastern North Carolina.
    Spangler JG; Michielutte R; Bell RA; Knick S; Dignan MB; Summerson JH
    Prev Med; 2001 Jun; 32(6):521-8. PubMed ID: 11394956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selected psychophysiological stress responses in men with high and low body fatness.
    Sothmann MS; Hart BA; Horn TS
    Med Sci Sports Exerc; 1995 Mar; 27(3):417-22. PubMed ID: 7752870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of oral smokeless tobacco on the cardiorespiratory response to exercise.
    Van Duser BL; Raven PB
    Med Sci Sports Exerc; 1992 Mar; 24(3):389-95. PubMed ID: 1549035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulatory disease and smokeless tobacco in Western populations: a review of the evidence.
    Lee PN
    Int J Epidemiol; 2007 Aug; 36(4):789-804. PubMed ID: 17591642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal smokeless tobacco effects on the rat fetus.
    Paulson RB; Shanfeld J; Mullet D; Cole J; Paulson JO
    J Craniofac Genet Dev Biol; 1994; 14(1):16-25. PubMed ID: 8006115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.
    Ramaekers JG; Kauert G; Theunissen EL; Toennes SW; Moeller MR
    J Psychopharmacol; 2009 May; 23(3):266-77. PubMed ID: 18719045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of short-term smokeless tobacco deprivation on performance.
    Keenan RM; Hatsukami DK; Anton DJ
    Psychopharmacology (Berl); 1989; 98(1):126-30. PubMed ID: 2498956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and autonomic effects of smokeless tobacco in healthy young men.
    Wolk R; Shamsuzzaman AS; Svatikova A; Huyber CM; Huck C; Narkiewicz K; Somers VK
    J Am Coll Cardiol; 2005 Mar; 45(6):910-4. PubMed ID: 15766828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
    Jones HE; Bigelow GE; Preston KL
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smokeless tobacco use in the United States: the adult use of tobacco surveys.
    Novotny TE; Pierce JP; Fiore MC; Davis RM
    NCI Monogr; 1989; (8):25-8. PubMed ID: 2785647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.